Haluk Tezcan, MD, Droplet’s CMO, will moderate a multidisciplinary physician panel discussing clinical use of LymphDetect™ technology for assessing MRD using surgical drain fluid for patients with HPV (-) Head and Neck cancer.

We will follow up with an invitation including additional details closer to the meeting.